NPY and glioblastoma: Although some GBM-basednanocarriers have been tested both in vitro and in vivo, a thoroughcharacterization of covalent binding impact on the biological propertiesof the carried molecule and/or of the nanomaterial is still missing.Here, a copper(I)-catalyzed alkyne–azide cycloaddition strategywas employed to synthesize the GO–NPY complex.